Trial led Nashat Gabrail, M.D., will assess dose-finding, safety and preliminary efficacy of STAR-LLD plus elranatamab ...

By using mRNA molecules to “remodel” parts of the immune system, researchers generated T cells that can slow the growth of ...

Final phase 1 results showed lasting responses to soquelitinib in some patients with relapsed or refractory T cell lymphoma.

Chemotherapy remains what many people picture when they hear a cancer diagnosis, but treatment for certain blood cancers now ...

Beyond the potential clinical application, the study sheds new light on T cell biology and how cells are directed towards specific lineages.

The immune system may learn not to attack the body by using a small but representative sample of the body’s own protein ...

Zika virus has been spreading for decades, but it first grabbed worldwide headlines in 2016. That February, with an outbreak ...

The immune system possesses legions of T cells that, if primed, could hunt down and destroy tumors. Now, a UC San Francisco ...

T cells may be able to do something scientists did not previously know they could: physically sense the tissues around them. A McGill University -led study suggests this ability could reshape ...

Researchers at MIT have found a way to use a nontoxic antifreeze sugar to protect CAR-T cells from damage during storage and ...

Dr. Porter frames access as CAR T-cell therapy's central challenge, outlining the safety, efficacy, and affordability gains still needed before outpatient administration can meaningfully close the gap ...